GMIP Inhibitors
GMIP inhibitors encompass a range of compounds that target various signaling pathways and cellular processes involved in actin cytoskeleton dynamics, cell motility, and cell contractility. Wortmannin and LY294002, as PI3K inhibitors, can suppress the PI3K/Akt signaling cascade, which is known to be upstream of GMIP's action in cell migration and cytoskeletal reorganization. The inhibition of PI3K leads to a decrease in Akt-mediated signaling, which is instrumental in various cellular processes including those regulated by GMIP. U0126 and PD98059, both MEK inhibitors, prevent the activation of the MAPK/ERK pathway, which is crucial for cell movement and proliferation. GMIP's role in MAPK-dependent cell movement can thus be attenuated by these inhibitors. Similarly, SB203580, by inhibiting p38 MAPK, can interfere with GMIP's involvement in stress fiber formation, a process vital for maintaining cell shape and motility under stress conditions.
In addition to these inhibitors, Y-27632 and Blebbistatin target the actomyosin cytoskeleton, which GMIP is known to regulate. Y-27632 inhibits ROCK, a kinase that is essential for actin-myosin contraction, thus potentially inhibiting GMIP's role in stress fiber stabilization. Blebbistatin, by inhibiting myosin II, affects myosin-driven cell contractility where GMIP is involved. ML-7, another compound targeting the actomyosin interaction, works by inhibiting myosin light chain kinase, which disrupts actin-myosin interactions that GMIP regulates. These inhibitors, therefore, can indirectly inhibit GMIP by destabilizing the actin cytoskeleton and inhibiting cell contractility. SP600125, a JNK inhibitor, and NSC23766, a Rac1 inhibitor, target signaling pathways involved in actin polymerization and cell migration, both of which are processes where GMIP is known to play a significant role.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that impedes the Akt signaling pathway. GMIP is involved in cellular processes regulated by the PI3K/Akt pathway, and inhibition of this pathway can suppress GMIP-mediated cellular migration and cytoskeletal reorganization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that blocks the PI3K/Akt pathway. By inhibiting this pathway, LY294002 reduces the downstream signaling that is crucial for GMIP's role in actin cytoskeleton dynamics and cell motility. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that prevents activation of MAPK/ERK pathway. As GMIP is implicated in the regulation of MAPK-dependent cell movement, the inhibition of MEK can attenuate GMIP's facilitation of cytoskeletal reorganization. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can diminish the cellular response to stress signals. GMIP is known to interact with components of the MAPK pathway; thus, hindering p38 MAPK can inhibit GMIP's involvement in stress fiber formation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that reduces actin-myosin contraction. Given that GMIP is associated with the regulation of actin cytoskeleton, the suppression of ROCK can inhibit GMIP's role in stress fiber stabilization. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Myosin II inhibitor that prevents myosin-driven cell contractility. As GMIP interacts with the actomyosin cytoskeleton, inhibiting myosin II activity can disrupt GMIP's regulatory function in cell shape and motility. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Myosin light chain kinase inhibitor that reduces myosin activation. GMIP's function in actin dynamics and cell contractility can be inhibited by ML-7, as it interferes with actin-myosin interactions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that impedes the JNK signaling pathway. By hindering JNK, SP600125 can inhibit GMIP's role in the regulation of cellular processes that are dependent on the JNK pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that blocks the ERK/MAPK pathway. By inhibiting MEK, PD98059 can disrupt GMIP's associated signaling pathways, ultimately reducing GMIP's regulatory role in cell adhesion and migration. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
Formin inhibitor that disrupts actin nucleation and elongation. GMIP's role in actin filament stabilization can be inhibited by SMIFH2, as it impedes formin-mediated actin dynamics. | ||||||